Searchable abstracts of presentations at key conferences in endocrinology

ea0029p481 | Developmental endocrinology | ICEECE2012

Regulation of trophoblast 11β-hydroxysteroid dehydrogenase type 2 expression and role of corticotropin-releasing hormone

Hein A. , Vatish M. , Grammatopoulos D.

The formation of the placental syncytiotrophoblast through trophoblast differentiation is a key cellular event, essential for successful embryonic implantation, oxygen/nutrient transport and secretion of placental hormones necessary for fetal development. Trophoblast differentiation alters expression of various molecules with important roles in placental biology, including 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2), the major component of the placental glucoc...

ea0011s35 | Clinical lessons from novel aspects of G protein-coupled receptors signalling | ECE2006

Alpha- and beta-adrenoceptor dysfunction

Hein L , Beetz NB , Knaus A , Muthig V

The family of adrenergic receptors contains nine different subtypes of G protein-coupled receptors which mediate the biological effects of adrenaline and noradrenaline. With few exceptions, the full therapeutic potential of subtype-selective therapy has not yet been explored for the group of adrenergic receptors. In the absence of sufficiently subtype-selective ligands which can distinguish between individual receptor subtypes of the adrenergic family, gene-targeted mouse mode...

ea0090p272 | Late-Breaking | ECE2023

Management of Thyroid Nodules- a single centre experience/ a district Hospital Experience

Lin Htut Thein , Mlawa Gideon , Mahmood Rabia , Hein Thura , Sadulah Dalya , Sreejith Gopika , Latif Yasser

Background: A thyroid nodule is a discrete lesion within the thyroid gland, which can serve as a prelude to a spectrum of conditions ranging from a benign incidental growth to a full-blown invasive carcinoma. Thyroid nodules are very common in adult population. About 15% of the UK population have clinically detectable goitres or thyroid nodules, and the lifetime risk of developing a thyroid nodule is around 5 to 10%. In addition, there is increasing risk of thyroid cancers in ...

ea0099p584 | Late-Breaking | ECE2024

Long-term bone health in women with a premenopausal risk-reducing salpingo-oophorectomy (RRSO) compared with women who underwent

Beekman Maarten , Terra Lara , Stuursma Anniek , Heemskerk-Gerritsen Bernadette , van Beurden Marc , van Doorn Lena , van Dorst Eleonora , de Hullu Joanne , Mom Stijn , Roeters van Lennep Jeanine , Gaarenstroom Katja , Korse Tiny , de Keizer Bart , Mitea Cristina , Slart Riemer , Miranda Snoeren , Stokkel Marcel , Verberne Hein , van Asperen Christi , Ausems Margreet , Berger Lieke , de Bock Truuske , Margriet Collee , van Engelen Klaartje , van der Kolk Lizet , Wevers Marijke , Gomez Garcia Encarna , Hooning Maartje , Maas Angela , Mourits Marian , van Leeuwen Flora , Zillikens Carola

Introduction: To prevent ovarian cancer, BRCA1/2 germline pathogenic variant carriers are recommended to undergo premenopausal risk-reducing salpingo-oophorectomy (RRSO). Premenopausal RRSO leads to immediate surgical menopause, which has been associated with an acute phase of rapid bone loss. However, data on long-term effects is scarce and inconclusive. Therefore, we investigated the long-term impact of premenopausal RRSO on bone mineral density (BMD).<p class="...